Dr. Paul Lohmann partners with AloxX and the Otto von Guericke University Magdeburg

Dr. Paul Lohmann announces the cooperation with AloxX and the Otto von Guericke University Magdeburg (OVGU) in the field of innovative corrosion protection additives under the brand Lohtragon CP.

The three parties intend to sign an exclusive licensing agreement covering novel corrosion protection additives. Based on the invention of the Swiss company AloxX and the OVGU, Dr. Paul Lohmann will exclusively be in charge of production, product optimization as well as global sales and marketing of this additive range. The technology has the potential to replace most corrosion additive packages currently in use in aqueous systems. The industry is put under immense pressure towards the R&D of environmentally sustainable solutions. Lohtragon CP is categorized as a GRAS (generally recognized as safe) chemical and demonstrates an important step towards reinventing the corrosion industry.

A full range of Lohtragon CP products will be developed during an initial pilot phase to make sure to meet all the requirements of the customers.

© Dr. Paul Lohmann
© Dr. Paul Lohmann

Company

Logo:

Dr. Paul Lohmann GmbH & Co. KGaA

Hauptstr. 2
31860 Emmerthal
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.